IMPACT BIOMEDICAL INC. — Investor Relations & Filings
Filings indexed
121
across all filing types
Latest filing
2026-04-22
Regulatory Filings
Country
US
United States of America
Listing
US
IBO
Impact Biomedical Inc. is a biotechnology company that discovers, validates, patents, and develops science and technologies into innovative solutions for human health and wellness. Operating under the principle "Inspired by Nature, Powered by Science," the company focuses on creating new offerings and treatment options to address unmet healthcare needs. Its activities include the development of products in specialty biopharmaceuticals and the acquisition of technologies designed to protect against pathogens.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| S-8 POS - IMPACT BIOMEDICAL INC. (0001834105) (Filer) | 2026-04-22 | English | |
| S-8 POS - IMPACT BIOMEDICAL INC. (0001834105) (Filer) | 2026-04-06 | English | |
| 4 - IMPACT BIOMEDICAL INC. (0001834105) (Issuer) | 2026-03-26 | English | |
| 8-K - IMPACT BIOMEDICAL INC. (0001834105) (Filer) | 2026-03-04 | English | |
| 4 | 2026-01-06 | English | |
| DEF 14C | 2025-12-30 | English |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
5 filings
| |||||
| 35404616 | S-8 POS - IMPACT BIOMEDICAL INC. (0001834105) (Filer) | 2026-04-22 | English | ||
| 33642068 | S-8 POS - IMPACT BIOMEDICAL INC. (0001834105) (Filer) | 2026-04-06 | English | ||
| 33043573 | 4 - IMPACT BIOMEDICAL INC. (0001834105) (Issuer) | 2026-03-26 | English | ||
| 32899433 | 8-K - IMPACT BIOMEDICAL INC. (0001834105) (Filer) | 2026-03-04 | English | ||
| 13345710 | 4 | 2026-01-06 | English | ||
|
2025
10 filings
| |||||
| 13345714 | DEF 14C | 2025-12-30 | English | ||
| 13345717 | PRE 14C | 2025-12-11 | English | ||
| 13345718 | 10-Q | 2025-11-07 | English | ||
| 13345726 | 8-K | 2025-11-06 | English | ||
| 13345728 | 8-K | 2025-10-27 | English | ||
| 13345719 | DEF 14A | 2025-09-22 | English | ||
| 13345721 | DEF 14C | 2025-09-09 | English | ||
| 13345722 | PRE 14C | 2025-08-26 | English | ||
| 13345723 | 10-Q | 2025-08-14 | English | ||
| 13345724 | DEF 14C | 2025-08-05 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
CHAMPIONS ONCOLOGY, INC.
A CRO providing end-to-end solutions to accelerate oncology…
|
CSBR | US | Professional, scientific and te… |
|
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
A contract research organization supporting drug discovery …
|
CRL | US | Professional, scientific and te… |
|
ChemPartner PharmaTech Co., Ltd.
Global CRO and CDMO providing integrated drug discovery and…
|
300149 | CN | Professional, scientific and te… |
|
CHIMERIC THERAPEUTICS LIMITED
Clinical-stage cell therapy company developing CAR T and NK…
|
CHM | AU | Professional, scientific and te… |
|
China National Electric Apparatus Research Institute Co., Ltd.
R&D institution for electrical and electronics testing, equ…
|
688128 | CN | Professional, scientific and te… |
|
Chiome Bioscience Inc.
Clinical-stage biotech company developing antibody-based th…
|
4583 | JP | Professional, scientific and te… |
|
CHITOGENX INC
Clinical stage regenerative medicine company focused on nov…
|
CHGX | CA | Professional, scientific and te… |
|
Chordate Medical Holding AB
Develops a patented, drug-free neuromodulation treatment fo…
|
CMH | SE | Professional, scientific and te… |
|
Chordia Therapeutics,Inc
Clinical-stage biotech developing novel cancer therapies ta…
|
190A | JP | Professional, scientific and te… |
|
Cibus, Inc.
Develops and licenses plant traits using non-GMO precision …
|
CBUS | US | Professional, scientific and te… |
IMPACT BIOMEDICAL INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35295/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35295 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35295 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35295 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35295}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for IMPACT BIOMEDICAL INC. (id: 35295)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.